Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index; 26 of the 48 sources its claims cite were checked for support.
Abstract
Candida albicans is the leading fungal pathogen of humans, causing life-threatening disease in immunocompromised individuals. Treatment of candidiasis is hampered by the limited number of antifungal drugs whose efficacy is compromised by host toxicity, fungistatic activity, and the emergence of drug resistance. We previously established that the molecular chaperone Hsp90, which regulates the form and function of diverse client proteins, potentiates resistance to the azoles in C. albicans and in the model yeast Saccharomyces cerevisiae. Genetic studies in S. cerevisiae revealed that Hsp90's role in azole resistance is to enable crucial cellular responses to the membrane stress exerted by azoles via the client protein calcineurin. Here, we demonstrate that Hsp90 governs cellular circuitry required for resistance to the only new class of antifungals to reach the clinic in decades, the echinocandins, which inhibit biosynthesis of a critical component of the fungal cell wall. Pharmacological or genetic impairment of Hsp90 function reduced tolerance of C. albicans laboratory strains and resistance of clinical isolates to the echinocandins and created a fungicidal combination. Compromising calcineurin function phenocopied compromising Hsp90 function. We established that calcineurin is an Hsp90 client protein in C. albicans: reciprocal co-immunoprecipitation validated physical interaction; Hsp90 inhibition blocked calcineurin activation; and calcineurin levels were depleted upon genetic reduction of Hsp90. The downstream effector of calcineurin, Crz1, played a partial role in mediating calcineurin-dependent stress responses activated by echinocandins. Hsp90's role in echinocandin resistance has therapeutic potential given that genetic compromise of C. albicans HSP90 expression enhanced the efficacy of an echinocandin in a murine model of disseminated candidiasis. Our results identify the first Hsp90 client protein in C. albicans, establish an entirely new role for Hsp90 in mediating resistance to echinocandins, and demonstrate that targeting Hsp90 provides a promising therapeutic strategy for the treatment of life-threatening fungal disease.
Overview
CoChat Summary
## TL;DR
Hsp90 is required for *Candida albicans* tolerance to echinocandins, and this effect depends largely on calcineurin. Genetic or pharmacological impairment of Hsp90 or calcineurin made micafungin more effective in vitro and in a murine disseminated infection model.
## Key findings
- In antifungal susceptibility and spotting assays, inhibiting Hsp90 with geldanamycin (GdA) or radicicol (RAD) “dramatically enhanced” sensitivity to micafungin (MF) in two strains, and comparable effects were seen with caspofungin (CS).
- Compromising Hsp90 function made the tetO-HSP90/hsp90Δ strain hypersensitive to MF even without tetracycline, and restoring a wild-type HSP90 allele complemented both the reduced growth rate and MF hypersensitivity.
- Inhibiting calcineurin with cyclosporin A (CsA) or FK506 abolished MF tolerance; deleting CNA1 or CNB1 also abrogated MF tolerance, while CRZ1 deletion caused only a partial loss of MF tolerance.
- In the murine model, mice infected with the tetO-HSP90/hsp90Δ strain had significantly reduced kidney fungal burden than mice infected with wild-type HSP90 strain (P<0.05), and MF further reduced fungal burden in the tetO-HSP90/hsp90Δ group (P<0.001).
## Methods
- The study combined pharmacological inhibition (GdA, RAD, CsA, FK506) and genetic perturbation (HSP90, CNA1, CNB1, CRZ1 mutants; tetO-HSP90/hsp90Δ; MAL2p-HSP90/hsp90Δ) in *C. albicans* and *S. cerevisiae*.
- Antifungal tolerance was measured using modified broth microdilution MIC assays, checkerboard synergy assays, and spotting assays on liquid and solid media with MF and CS.
- Mechanistic tests included β-galactosidase reporter assays for calcineurin activation, co-immunoprecipitation of tagged Hsp90 and Cna1, immunoblotting for protein levels, and a tail-vein murine disseminated candidiasis model with kidney CFU readout.
## Limitations
- The paper explicitly notes that the basis for the different responses with micafungin and caspofungin on solid medium is unclear, and the response with anidulafungin “remains to be determined.”
- The authors state that synergy between Hsp90/calcineurin inhibitors and MF was not observed for all echinocandin-resistant clinical isolates tested; of 14 FKS1 mutants, synergy was observed for 8.
- Evidence on cidality was limited by MF-induced clumping, which made CFU counts inaccurate in the echinocandin killing assay; this is stated in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
19 Valid · 3 Not valid · 19 Not checked · 75 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“This antibody also demonstrated synergy with the echinocandin caspofungin in a murine model [53].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [53] S Hodgetts, 2008, Efungumab and caspofungin: pre-clinical data supporting synergy., J Antimicrob Chemother source
The Introduction identifies efungumab as a human recombinant antibody fragment against Hsp90. The Abstract reports a statistically significant improvement with efungumab plus caspofungin in mice infected with fluconazole-resistant C. albicans, supporting the claimed synergy in a murine model. (LLM, conf=0.93)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Current Hsp90 inhibitors that are well-tolerated in humans as anti-cancer agents exhibit toxicity in the mouse model in the context of an acute fungal infection [22].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [22] LE Cowen, 2009, Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease., Proc Natl Acad Sci U S A source
The Discussion states that Hsp90 inhibitors in clinical development as anticancer agents are well tolerated in humans. It also reports significant toxicity with two structurally unrelated Hsp90 inhibitors in a mouse model of acute disseminated C. albicans infection. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in an invertebrate model of fungal pathogenesis, these pharmacological inhibitors of Hsp90 function enhance the efficacy of the two most widely deployed classes of antifungal drugs, azoles and echinocandins, against the two leading fungal pathogens of humans, Candida albicans and Aspergillus fumigatus [22].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [22] LE Cowen, 2009, Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease., Proc Natl Acad Sci U S A source
The Abstract describes improved efficacy of fluconazole plus Hsp90 inhibitors against C. albicans in Galleria mellonella larvae, and improved larval survival with an Hsp90 inhibitor plus caspofungin against A. fumigatus. The Discussion likewise reports that combination therapy rescued lethal infections with both fungi in this invertebrate host. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This recombinant antibody had therapeutic benefits in a clinical trial in combination with amphotericin B, which targets ergosterol [52].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [52] J Pachl, 2006, A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis., Clin Infect Dis source
The Abstract identifies Mycograb as a recombinant antibody against fungal heat shock protein 90 and reports better treatment responses when it was combined with lipid-associated amphotericin B than when amphotericin B was given with placebo. The Discussion likewise describes improved clinical and mycological resolution. These passages support the claimed therapeutic benefit in the clinical trial. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Consistent with previous findings [23], we confirmed that Hsp90 and calcineurin physically interact in S. cerevisiae (Figure 9A), as they do in C. albicans (Figure 4).”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Results > Divergence of Hsp90 and calcineurin's role in echinocandin tolerance in S. cerevisiae
What the sources say
- Supportedcites [23] J Imai, 2000, Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin., Mol Cell Biol source
The Abstract reports that Hsc82, a yeast HSP90 homologue, coimmunoprecipitated with the calcineurin catalytic subunit Cna2 in Saccharomyces cerevisiae cells under normal conditions. The Discussion also says coimmunoprecipitation experiments revealed complexes of Cna2 with Hsp82 and Hsc82, supporting the attributed physical interaction. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
56 more claims · 1 with their cited sources checked
Create a free account to see all 116 claims and every source verdict.
- Probably not a substantial claim. 35
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hsp90 enables crucial responses to drug-induced stress by orchestrating signaling through the protein phosphatase calcineurin and the protein kinase C (PKC) cell wall integrity signaling cascade [41], [46].”
From Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata (2012) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In C. albicans, key client proteins of Hsp90 include the Ca2+-calmodulin-activated protein phosphatase calcineurin, and multiple members of the PKC-MAPK cell wall integrity cascade (Pkc1, Bck1, Mkk2 and Mkc1)75–78.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, Hsp90 inhibition blocks the activation of calcineurin-dependent stress responses and PKC signalling, abrogating tolerance and resistance to the azole and echinocandin drugs76,78.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hsp90 depletion phenocopies the azole sensitivity of calcineurin and protein kinase C mutants96,101.”
From Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs (2012) · cites this paper as [96]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Candida albicans and Aspergillus fumigatus, role of Hsp90 in echinocandin resistance has been well established [10].”
From Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans (2017) · cites this paper as [10]
Experimental — accuracy not yet measured
26 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“and are responsible for a broad spectrum of disease [1,2].”
BackgroundGlobal analysis of protein expression in yeast
Ghaemmaghami, S., Huh, W.-K., Bower, K., Howson, R. W., Belle, A., Dephoure, N., O'Shea, E. K., & Weissman, J. S. (2003) · Nature · doi:10.1038/nature02046 · Cited by 3,750 · cited 1×
“cerevisiae [36].”
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304 · cited 1×
“fumigatus is the principal causal agent of invasive aspergillosis with alarming mortality rates up to 90% that still remain at 40% with the best current treatment options [25,26].”
BackgroundPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483 · cited 1×
“Hsp90 is an essential chaperone that regulates the form and function of many key signal transducers [17–19].”
BackgroundWhitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444 · cited 1×
“[32,33].”
Structure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103 · cited 1×
“Hsp90 is an essential chaperone that regulates the form and function of many key signal transducers [17–19].”
BackgroundRoles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069 · cited 1×
“Consistent with this thinking, heat-shock proteins are immunodominant antigens for the recognition of many pathogens and play a central role in mediating both innate and adaptive immune responses [54,55].”
BackgroundRoe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004 · cited 1×
“[32,33].”
Zhao, R., Davey, M., Hsu, Y.-C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., et al. (2005) · Cell · doi:10.1016/j.cell.2004.12.024 · Cited by 819 · cited 2×
“cerevisiae [24], while to date not a single Hsp90 client protein has been characterized in C.”
BackgroundZaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784 · cited 1×
“[2,3].”
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 10×
“The key mediator of Hsp90-dependent azole resistance is calcineurin, a protein phosphatase that regulates crucial responses to environmental stress, including the membrane stress exerted by exposure to azoles [20,21].”
BackgroundMethodInfluentialSelf-citationMonophyletic Origins of the Metazoa: an Evolutionary Link with Fungi
Wainright, P. O., Hinkle, G., Sogin, M. L., & Stickel, S. K. (1993) · Science · doi:10.1126/science.8469985 · Cited by 667 · cited 1×
“Fungi are eukaryotes and share close evolutionary relationships with their human hosts [6,7].”
BackgroundTrends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657
Borkovich, K. A., Farrelly, F. W., Finkelstein, D. B., Taulien, J., & Lindquist, S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3919 · Cited by 641
Aspergillus Infections in Transplant Recipients
Singh, N., & Paterson, D. L. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.44-69.2005 · Cited by 579 · cited 1×
“fumigatus is the principal causal agent of invasive aspergillosis with alarming mortality rates up to 90% that still remain at 40% with the best current treatment options [25,26].”
BackgroundWandinger, S. K., Richter, K., & Buchner, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800007200 · Cited by 546
Animals and fungi are each other's closest relatives: congruent evidence from multiple proteins.
Baldauf, S. L., & Palmer, J. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11558 · Cited by 543 · cited 1×
“Fungi are eukaryotes and share close evolutionary relationships with their human hosts [6,7].”
BackgroundResistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · cited 1×
“The most common mechanism of echinocandin resistance is mutation of the drug target [11].”
BackgroundInvasive fungal infections: a review of epidemiology and management options
Enoch, D. A., Ludlam, H. A., & Brown, N. M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46548-0 · Cited by 501 · cited 2×
“individuals undergoing chemotherapy, transplantation of solid organs or hematopoietic stem cells, as well as those infected with HIV [4,5].”
BackgroundStimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · cited 3×
“albicans from echinocandins and this stimulation is mediated via calcineurin in concert with the cell wall integrity signaling pathway and the high osmolarity glycerol signaling pathway [15,16].”
BackgroundStathopoulos, A. M., & Cyert, M. S. (1997) · Genes & Development · doi:10.1101/gad.11.24.3432 · Cited by 442 · cited 1×
“, is regulated by both PKC signaling and calcineurin”
BackgroundCowen, L. E., Singh, S. D., Köhler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813394106 · Cited by 413 · cited 10×
“Due to toxicity of currently available Hsp90 inhibitors that do not distinguish pathogen from host in the context of an acute fungal infection [22], we used genetic regulation of HSP90 to test this hypothesis in an in vivo system.”
BackgroundMethodInfluentialSelf-citationYoshimoto, H., Saltsman, K., Gasch, A. P., Li, H. X., Ogawa, N., Botstein, D., Brown, P. O., & Cyert, M. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202718200 · Cited by 404
Evolution of antifungal-drug resistance: mechanisms and pathogen fitness
Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375 · cited 1×
“In experimental populations and clinical isolates, resistance often emerges by multiple mechanisms [8–10].”
BackgroundThe direct cost and incidence of systemic fungal infections
Wilson, L. S., Reyes, C. M., Stolpman, M., Speckman, J., Allen, K., & Beney, J. (2002) · Value in Health · doi:10.1046/j.1524-4733.2002.51108.x · Cited by 374 · cited 2×
“individuals undergoing chemotherapy, transplantation of solid organs or hematopoietic stem cells, as well as those infected with HIV [4,5].”
BackgroundSanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350 · cited 2×
“Whether calcineurin mediates basal tolerance to echinocandins is unclear given that in one study, deletion of calcineurin enhanced the killing activity of an echinocandin [30], while in another study there was no effect [31].”
BackgroundCalcineurin is essential for survival during membrane stress in Candida albicans
Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342 · cited 2×
“Whether calcineurin mediates basal tolerance to echinocandins is unclear given that in one study, deletion of calcineurin enhanced the killing activity of an echinocandin [30], while in another study there was no effect [31].”
BackgroundSelf-citationHarnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Steinbach, W. J., Reedy, J. L., Cramer, R. A., Perfect, J. R., & Heitman, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1680 · Cited by 313 · cited 1×
“Perhaps in a related manner, the utility of calcineurin inhibitors in antifungal therapy has been complicated by their immunosuppressive effects [57].”
BackgroundHsp90 Orchestrates Temperature-Dependent Candida albicans Morphogenesis via Ras1-PKA Signaling
Shapiro, R. S., Uppuluri, P., Zaas, A. K., Collins, C., Senn, H., Perfect, J. R., Heitman, J., & Cowen, L. E. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.017 · Cited by 311
Self-citationThe evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311 · cited 2×
“Most antifungal drugs in clinical use target the biosynthesis or function of ergosterol, the predominant sterol of fungal membranes, or the biosynthesis of (1,3)-b-Dglucan, a critical component of the fungal cell wall [8,9].”
BackgroundSelf-citationMunro, C. A., Selvaggini, S., De Bruijn, I., Walker, L., Lenardon, M. D., Gerssen, B., Milne, S., Brown, A. J. P., & Gow, N. A. R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05588.x · Cited by 309 · cited 3×
“albicans from echinocandins and this stimulation is mediated via calcineurin in concert with the cell wall integrity signaling pathway and the high osmolarity glycerol signaling pathway [15,16].”
BackgroundPachl, J., Svoboda, P., Jacobs, F., Vandewoude, K., van der Hoven, B., Spronk, P., Masterson, G., Malbrain, M., Aoun, M., Garbino, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503428 · Cited by 307 · cited 1×
“This recombinant antibody had therapeutic benefits in a clinical trial in combination with amphotericin B, which targets ergosterol [52].”
BackgroundStress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285 · cited 2×
“Most antifungal drugs in clinical use target the biosynthesis or function of ergosterol, the predominant sterol of fungal membranes, or the biosynthesis of (1,3)-b-Dglucan, a critical component of the fungal cell wall [8,9].”
BackgroundSelf-citationGarcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · cited 1×
“Resistance is most commonly associated with characteristic mutations in FKS1 that reduce sensitivity of the enzyme to inhibition by echinocandins [11–13].”
BackgroundStathopoulos-Gerontides, A., Guo, J. J., & Cyert, M. S. (1999) · Genes & Development · doi:10.1101/gad.13.7.798 · Cited by 240 · cited 2×
“cerevisiae, a similar reporter that contains four tandem copies of CDRE and a CYC1 minimal promoter driving lacZ has been used extensively [39].”
MethodCRZ1 , a target of the calcineurin pathway in Candida albicans
Karababa, M., Valentino, E., Pardini, G., Coste, A. T., Bille, J., & Sanglard, D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05037.x · Cited by 231 · cited 2×
“We used a strain harboring a construct with the UTR2 promoter, which contains a CDRE element and is regulated by calcineurin [37], fused to lacZ and integrated at the UTR2 locus [40].”
BackgroundMethodCalcineurin: Structure, function, and inhibition
Hemenway, C. S., & Heitman, J. (1999) · Cell Biochemistry and Biophysics · doi:10.1007/bf02737887 · Cited by 227 · cited 1×
“We initially compromised calcineurin function pharmacologically using two structurally unrelated inhibitors cyclosporin A (CsA) and FK506 that inhibit calcineurin by distinct mechanisms [34].”
MethodBalashov, S. V., Park, S., & Perlin, D. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-05 · Cited by 225 · cited 2×
“To determine if the synergy between GdA or CsA and MF was conserved in an isolate that evolved echinocandin resistance in a human host, we tested a clinical isolate harboring the same F641S Fks1 mutation (DPL15, generously provided by D. S. Perlin).”
MethodZhao, C., Jung, U. S., Garrett-Engele, P., Roe, T., Cyert, M. S., & Levin, D. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1013 · Cited by 209 · cited 1×
“cerevisiae, expression of one of the two partially redundant genes encoding the essential (1,3)-bD-glucan synthase activity, FKS2, is regulated by both PKC signaling and calcineurin [46,47].”
BackgroundReinoso-Martín, C., Schüller, C., Schuetzer-Muehlbauer, M., & Kuchler, K. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1200-1210.2003 · Cited by 193 · cited 1×
“cerevisiae [44,45].”
Millson, S. H., Truman, A. W., King, V., Prodromou, C., Pearl, L. H., & Piper, P. W. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.5.849-860.2005 · Cited by 172
Fortwendel, J. R., Juvvadi, P. R., Pinchai, N., Perfect, B. Z., Alspaugh, J. A., Perfect, J. R., & Steinbach, W. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01154-08 · Cited by 161 · cited 1×
“Compromising calcineurin tracks with compromising Hsp90, enhancing the activity of echinocandins [27,28].”
BackgroundSelf-citationGenetic Architecture of Hsp90-Dependent Drug Resistance
Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R., & Lindquist, S. (2006) · Eukaryotic Cell · doi:10.1128/ec.00274-06 · Cited by 159 · cited 5×
“The key mediator of Hsp90-dependent azole resistance is calcineurin, a protein phosphatase that regulates crucial responses to environmental stress, including the membrane stress exerted by exposure to azoles [20,21].”
BackgroundMethodInfluentialSelf-citationThe MAP kinase Mkc1p is activated under different stress conditions in Candida albicans
Navarro-García, F., Eisman, B., Fiuza, S. M., Nombela, C., & Pla, J. (2005) · Microbiology · doi:10.1099/mic.0.28038-0 · Cited by 134 · cited 2×
“For example, Mkc1, the mitogen activated protein kinase (MAPK) in the PKC pathway, is activated by hydrogen peroxide but is not required for survival under this condition [43].”
BackgroundWiederhold, N. P., Kontoyiannis, D. P., Prince, R. A., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5146-5148.2005 · Cited by 131 · cited 1×
“albicans observed at elevated echinocandin concentrations [29].”
Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin.
Imai, J., & Yahara, I. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9262-9270.2000 · Cited by 123 · cited 3×
“cerevisiae, Hsp90 physically interacts with the catalytic subunit of calcineurin keeping it stable and poised for activation [23].”
BackgroundResultInfluentialMarkovich, S., Yekutiel, A., Shalit, I., Shadkchan, Y., & Osherov, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3871-3876.2004 · Cited by 122 · cited 1×
“cerevisiae [44,45].”
Onyewu, C., Wormley, F. L., Perfect, J. R., & Heitman, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7330-7333.2004 · Cited by 121 · cited 1×
“albicans [20,42].”
Self-citationGould, C. M., Kannan, N., Taylor, S. S., & Newton, A. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808436200 · Cited by 113 · cited 7×
“In S. cerevisiae, expression of one of the two partially redundant genes encoding the essential (1,3)-bD-glucan synthase activity, FKS2, is regulated by both PKC signaling and calcineurin [46,47].”
BackgroundInfluentialRoy, J., Li, H., Hogan, P. G., & Cyert, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.014 · Cited by 112 · cited 1×
“activation by calcium [37–39].”
Calcineurin Inhibition or Mutation Enhances Cell Wall Inhibitors against Aspergillus fumigatus
Steinbach, W. J., Cramer, R. A., Perfect, B. Z., Henn, C., Nielsen, K., Heitman, J., & Perfect, J. R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01394-06 · Cited by 108 · cited 1×
“Compromising calcineurin tracks with compromising Hsp90, enhancing the activity of echinocandins [27,28].”
BackgroundSelf-citationAn essential role of the yeast pheromone-induced Ca2+ signal is to activate calcineurin.
Withee, J. L., Mulholland, J., Jeng, R., & Cyert, M. S. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.2.263 · Cited by 80 · cited 1×
“Protein was extracted as described [46,58], and protein concentrations were determined by Bradford analysis.”
MethodHeat-shock proteins and the host-pathogen interaction during bacterial infection.
Stewart, G. R., & Young, D. B. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.05.007 · Cited by 79 · cited 1×
“Consistent with this thinking, heat-shock proteins are immunodominant antigens for the recognition of many pathogens and play a central role in mediating both innate and adaptive immune responses [54,55].”
BackgroundKumar, R., Musiyenko, A., & Barik, S. (2005) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2005.01.012 · Cited by 71 · cited 1×
“Inhibitors of Hsp90 and calcineurin both have potent anti-malarial activity, thus extending their impact to the protozoan parasite Plasmodium falciparum [56].”
BackgroundAttenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect
Wiederhold, N. P. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f1be7f · Cited by 65 · cited 1×
“albicans, this organism has the capacity for robust growth at high drug concentrations, known as the paradoxical effect [14].”
BackgroundDudgeon, D. D., Zhang, N., Ositelu, O. O., Kim, H., & Cunningham, K. W. (2008) · Eukaryotic Cell · doi:10.1128/ec.00291-08 · Cited by 59 · cited 1×
“Cases of discordance between the phenotypic effects of compromising Hsp90 versus compromising calcineurin may reflect the relative importance of other Hsp90 client proteins in a particular trait or may reflect specificity of the agents used to inhibit these regulators [51].”
BackgroundTruman, A. W., Millson, S. H., Nuttall, J. M., Mollapour, M., Prodromou, C., & Piper, P. W. (2007) · Eukaryotic Cell · doi:10.1128/ec.00009-07 · Cited by 59 · cited 2×
“cerevisiae, Hsp90 may also interact with PKC signaling by chaperoning PKC [48] and the MAPK Slt2 [49,50].”
BackgroundTandem affinity purification of the Candida albicans septin protein complex
Kaneko, A., Umeyama, T., Hanaoka, N., Monk, B. C., Uehara, Y., & Niimi, M. (2004) · Yeast · doi:10.1002/yea.1147 · Cited by 57
Isolation and partial characterization of Hsp90 from Candida albicans.
Burt, E. T., Daly, R., Hoganson, D., Tsirulnikov, Y., Essmann, M., & Larsen, B. (2003) · PubMed · Cited by 51
Efungumab and caspofungin: pre-clinical data supporting synergy.
Hodgetts, S., Nooney, L., Al-Akeel, R., Curry, A., Awad, S., Matthews, R., & Burnie, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn075 · Cited by 51 · cited 1×
“This antibody also demonstrated synergy with the echinocandin caspofungin in a murine model [53].”
Background
Cited by
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationThe Response to Heat Shock and Oxidative Stress in Saccharomyces cerevisiae
Morano, K. A., Grant, C. M., & Moye-Rowley, W. S. (2012) · Genetics · doi:10.1534/genetics.111.128033 · Cited by 652
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“Inhibition of Hsp90 reduces echinocandin resistance acquired by mutation in the drug target, and resistance that evolved in the human host (Singh et al. 2009; Singh-Babak et al. 2012).”
BackgroundInfluentialSelf-citationAntifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
“fumigatus, and that it is observed in an invertebrate model of candidiasis (Cowen et al. 2009; Singh et al. 2009; Shapiro et al. 2011).”
Background
Metadata
- Authors
- Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Duke Medical Center (US)
- Corresponding author
- Cowen, Leah E.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-07-31
- Volume
- 5
- Issue
- 7
- Pages
- e1000532
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2712069
- OpenAlex
- W2087273774
- Cited by
- 362
- References
- 60
- Citations by year
- 2026: 19 · 2025: 26 · 2024: 14 · 2023: 25 · 2022: 24 · 2021: 28 · 2020: 23 · 2019: 18 · 2018: 18 · 2017: 18 · 2016: 20 · 2015: 16 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Burroughs Wellcome Fund
- University of Toronto
- National Institutes of Health
- Canadian Institutes of Health Research (MOP-86452)
- Natural Sciences and Engineering Research Council of Canada
- National Institute of Allergy and Infectious Diseases (AI 73896, R56AI028388, AI28388, R01AI073896, R01AI028388, K08AI065837)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- HSP90, calcineurin, Candida albicans, echinocandin resistance, antifungal resistance, candidiasis, Hsp90 client proteins, Crz1, calcineurin signaling, molecular chaperones, fungal cell wall biosynthesis, HSP90 inhibition, combination antifungal therapy, systemic candidiasis
- MeSH terms
- Micafungin, Analysis of Variance, Animals, Antifungal Agents, Azoles, Candida albicans, Candidiasis, Disease Models, Animal, DNA-Binding Proteins, Fungal Proteins, Male, Stress, Physiological, Transcription Factors, HSP90 Heat-Shock Proteins, Calcineurin, Drug Resistance, Fungal, Mice, Echinocandins, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.